About Transcell Biosciences
Transcell Biosciences is a company based in Hyderabad (India) founded in 2009. It operates as a Managed Services and HealthTech. Transcell Biosciences has raised $2.21 million across 5 funding rounds from investors including Lemon Tree Hotels, Quantiphi and Primarc. Transcell Biosciences offers products and services including ScellCare, PREGEN, HSCT, BARTI, and TRUCB. Transcell Biosciences operates in a competitive market with competitors including StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
- Headquarter Hyderabad, India
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Transcell Biolife
-
Annual Revenue
$55.72 K (USD)-37as on Mar 31, 2023
-
Net Profit
-$86.22 K (USD)-18as on Mar 31, 2023
-
EBITDA
$3.44 K (USD)-88as on Mar 31, 2023
-
Total Equity Funding
$2.21 M (USD)
in 5 rounds
-
Latest Funding Round
$1.39 M (USD), Series A
Jul 19, 2024
-
Investors
Lemon Tree Hotels
& 72 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Transcell Biosciences
Transcell Biosciences offers a comprehensive portfolio of products and services, including ScellCare, PREGEN, HSCT, BARTI, and TRUCB.
Cord blood units are collected and stored compliantly.
Predictive and advisory services are provided with registration.
Damaged bone marrow is replaced for treatment.
Natural healing is promoted with tooth implants.
Plasma yields are enhanced for industrial applications.
Transformative medicinal applications are optimized through data.
Innovative drug solutions are developed for health.
Funding Insights of Transcell Biosciences
Transcell Biosciences has successfully raised a total of $2.21M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $1.39 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Transcell Biosciences
Transcell Biosciences has secured backing from 73 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Lemon Tree Hotels, Quantiphi and Primarc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Locked | Locked | Locked | |
|
Venture capital firm focused on seed-stage investments
|
Locked | Locked | Locked | |
|
Private investment arm of Kris Gopalakrishnan Family Office.
|
Locked | Locked | Locked |
Investor details for Transcell Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Transcell Biosciences
Investment portfolio details for Transcell Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Transcell Biosciences
Detailed financials for Transcell Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transcell Biosciences Comparisons
Peer comparison for Transcell Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Transcell Biosciences
Transcell Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| Locked | Locked | Locked |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| Locked | Locked | Locked |
Provider of services for the storage of stem cells
|
|
| Locked | Locked | Locked |
Stem Cell Production
|
|
| Locked | Locked | Locked |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| Locked | Locked | Locked |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Detailed competitors of Transcell Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transcell Biosciences
Complete news archive for Transcell Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transcell Biosciences
Transcell Biosciences was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Transcell Biosciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Transcell Biosciences is a funded company, having raised a total of $2.21M across 5 funding rounds to date.
Annual revenue of Transcell Biosciences is $55.72K as on Mar 31, 2023.
Stem cell banking and transformative medicinal applications are facilitated by Transcell Biosciences. Based in India, the company focuses on biobanking functions for personalized healthcare solutions. Services include cord blood storage, predictive advisory, stem cell transplantation, regenerative implants, plasma fractionation, population omics, and drug discovery. The healthcare sector is primarily served, with an emphasis on patient-centric and data-driven approaches. Innovative solutions are developed to address over 80 diseases through stem cell technology.
Transcell Biosciences's top competitors include StemCyte, Forever Labs and China Cord Blood.
Transcell Biosciences offers ScellCare, PREGEN, HSCT, BARTI, and 3 more products and services.
Transcell Biosciences has 73 investors. Key investors include Lemon Tree Hotels, Quantiphi, Primarc, Pidilite, and ADVIK Hi-Tech.
The valuation of Transcell Biosciences is $11.59M as of Jul 2024.